SCHEMBL13005504

SCHEMBL13005504

CC(C)Cc1cccc(CN(Cc2ccccc2F)[C@@H](CC(C)C)CN(C)C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 3/20 0.36
CETP P11597 1/20 0.36
SLC6A2 P23975 2/20 0.35
SLC6A3 Q01959 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GAA P10253 1/20 0.35
TAAR1 Q96RJ0 1/20 0.34
POLB P06746 1/20 0.34
AOC3 Q16853 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
GRIN3A Q8TCU5 1/20 0.32
LMNA P02545 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13005518 0.87 CETP (0.40) ALDH1A1CETPSLC6A2SLC6A3TAAR1
SCHEMBL13005520 0.86 LMNA (0.37) KDM4ECETPSLC6A2SLC6A3TAAR1
SCHEMBL13005522 0.86 CETP (0.36) CETPGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL13005507 0.86 TAAR1 (0.34) CETPTAAR1GRIN2DGRIN3BGRIN1
SCHEMBL13005500 0.86 GABRA1 (0.39) CETPPOLBGRIN2DGRIN3BGRIN1
SCHEMBL13005616 0.84 BCHE (0.40) CETPSLC6A2SLC6A3MEN1KMT2A
SCHEMBL13005513 0.84 CETP (0.32) CETPGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL13005611 0.84 CETP (0.34) ALDH1A1KDM4ECETPSMN1; SMN2GRIN2D
SCHEMBL13005613 0.84 GAA (0.39) ALDH1A1KDM4ECETPMEN1KMT2A
SCHEMBL13005641 0.83 SLC6A4 (0.41) CETPSLC6A2SLC6A3GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed